From Discovery To Development To Delivery

AZBio is committed to building a top-tier life science industry in Arizona.

Arizona’s bioscience industry is growing rapidly and reached nearly 30,000 jobs spanning 2,160 business establishments in 2018. Industry employment has grown by 15 percent since 2016—twice the growth rate of the nation—with each of the five major subsectors adding jobs during the period. Arizona’s universities conducted nearly $580 million in R&D activities in bioscience-related fields in 2018, fueled in part by steadily increasing NIH awards to Arizona institutions since 2016. Venture capital investments in Arizona bioscience companies increased in 2019, and during the 2016-19 period totaled $349 million. Arizona inventors have been awarded 2,178 bioscience-related patents since 2016, among the second quintile of states in patent activity.

IN THE LOOP

AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.

Subscribe

AZBio Members Are Making LIFE Bettter

AZBio Members discover, develop, and deliver life-saving and life-changing innovations.

Premiere Supporters

Leadership Supporters

Sustaining Members

Get Connected With Arizona's Bioindustry

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry.  AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.

 

Success Stories – Good News from Arizona’s BioIndustry

Join AZBio at the Personalized Medicine World Conference

PMWC 2012′s “Into The Clinic” session delves into both companies’ and clinicians’ perspectives with a particular focus on the benefits that patients presently gain from Personalized Medicine, as well as on approaches arriving in the near future. This is one of six sessions showcased in the PMWC 2012 program.    Join AZBio and come build your […]

National LambdaRail appoints Crow as head of Chairman’s Advisory Council

September 14, 2011 Patrick Soon-Shiong, chairman and CEO of National LambdaRail, announced the appointment of ASU President Michael M. Crow as head of a new Chairman’s Advisory Council.Aided by a $100 million guarantee from the Chan Soon-Shiong Institute for Advanced Health to upgrade and extend its network to support big science projects, the council will […]

Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference:  Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies. Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the […]

NCI SBIR offers $8M in new contract funding opportunities

The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Program recently announced $8 million in new contract funding opportunities to assist innovative small businesses with cancer research and technology development. This year, NCI SBIR has announced 12 new contract funding opportunities in a range of novel technology areas.

AZBio Builds Relationships With Partners Across The Country

Partner Opportunities for AZBio Members

  • Click the image to learn more